查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541234

2024-2032 年腸躁症治療市場報告（依類型（腹瀉型腸躁症、便秘型腸躁症、混合型腸躁症）、產品、配銷通路及地區

Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea, IBS with Constipation, Mixed IBS), Product, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球腸躁症治療市場規模達27億美元。

腸躁症（IBS）是指影響大腸的慢性疾病。它通常是由嚴重感染、壓力生活方式、腸道微生物變化、腸道肌肉收縮以及神經系統異常引起的。其特徵是脹氣、腹瀉、痙攣、腹脹、便秘、體重減輕、嘔吐、腹痛和吞嚥困難。目前有幾種藥物可以緩解 IBS 的輕微症狀，包括利福昔明、洛哌丁胺、瀉藥、解痙藥、纖維補充劑和薄荷油膠囊。醫生也推薦益生菌和心理健康療法，例如認知行為療法 (CBT)、腸道定向催眠療法和放鬆訓練來治療某些患者

腸躁症治療市場趨勢：

有幾個因素會增加腸躁症的風險，包括食物不耐症或過敏、消化道細菌感染、小腸細菌過度生長，以及焦慮、憂鬱和軀體症狀等精神障礙。這加上診斷方式的改善和醫療保健服務的便捷獲取，是推動市場成長的關鍵因素之一。此外，IBS是老年人中最常見的功能性胃腸道疾病之一。與此同時，全球不斷成長的老年人口正在對市場產生積極影響。除此之外，正在進行糞便微生物移植（FMT）等多項臨床試驗，以改善IBS的治療，這有助於市場成長。除此之外，作為永續發展目標 (SDG) 的一部分，各國管理機構承諾到 2030 年大幅增加研發 (R&D) 計畫支出和研究人員數量。

本報告回答的關鍵問題：

  • 迄今為止，全球腸躁症治療市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球腸躁症治療市場有何影響？
  • 主要區域市場有哪些？
  • 依類型分類市場是怎麼樣的？
  • 基於產品的市場區隔是什麼？
  • 基於配銷通路的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球腸躁症治療市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腸躁症治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 腹瀉型腸躁症 (IBS-D)
    • 市場趨勢
    • 市場預測
  • 伴隨便秘的 IBS (IBS-C)
    • 市場趨勢
    • 市場預測
  • 混合型腸躁症
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依產品

  • 利福昔明
    • 市場趨勢
    • 市場預測
  • 埃盧沙多林
    • 市場趨勢
    • 市場預測
  • 魯比前列酮
    • 市場趨勢
    • 市場預測
  • 利那洛肽
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 藥局和零售藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Allergan plc (AbbVie Inc.)
    • Ardelyx Inc.
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bausch Health Companies Inc.
    • GlaxoSmithKline Plc
    • Novartis AG
    • Sebela Pharmaceuticals Inc.
    • Synthetic Biologics Inc.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112024A4297

The global irritable bowel syndrome treatment market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032.

Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients

Irritable Bowel Syndrome Treatment Market Trends:

Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global irritable bowel syndrome treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product and distribution channel.

Breakup by Type:

IBS with Diarrhea (IBS-D)

IBS with Constipation (IBS-C)

Mixed IBS

Breakup by Product:

Rifaximin

Eluxadoline

Lubiprostone

Linaclotide

Others

Breakup by Distribution Channel:

Hospitals Pharmacies

Drug Stores and Retail Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report:

  • How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Irritable Bowel Syndrome Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 IBS with Diarrhea (IBS-D)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 IBS with Constipation (IBS-C)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Mixed IBS
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Rifaximin
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Eluxadoline
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Lubiprostone
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Linaclotide
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Stores and Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Allergan plc (AbbVie Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ardelyx Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 AstraZeneca plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Bausch Health Companies Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GlaxoSmithKline Plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sebela Pharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthetic Biologics Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
  • Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
  • Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
  • Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players